Text Message Gamification and Remote Support for Medication Adherence

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Ascension Health

Must be taking: Statins

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

2200 Participants Needed

Trial Summary

What is the purpose of this trial?

Statins have been demonstrated to significantly reduce the risk of cardiovascular disease, but adherence to these medications is suboptimal. Improving adherence can be challenging because it is multifactorial and behaviors often occur within the everyday lives of patients and are less addressable during a visit with a clinician. In this study, the investigators will conduct a randomized trial to evaluate a behaviorally-designed gamification intervention with remote nursing support to improve statin adherence.

Eligibility Criteria

This trial is for adults over 18 who have a primary care provider with Ascension, are on statin medication but haven't been taking it regularly, and are open to digital communication. They must have filled two statin prescriptions in the last year and be able to receive text messages or emails.

Inclusion Criteria

Have a primary care provider (PCP) employed by Ascension

PDC <80% in the prior 12 months

Have consented for electronic communications with Ascension

Exclusion Criteria

Patients will be excluded if they do not meet our inclusion criteria.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Intervention

Participants receive the MedTrack text message intervention and remote support

6 months

Follow-up

Participants are monitored for statin adherence and health outcomes after the intervention

4 weeks

Treatment Details

Interventions

• Text Message Gamification and Remote Support

Trial Overview The study tests if a game-like text messaging system combined with remote nursing support can help people stick to their statin medication routine better than usual care without these features.

Participant Groups

Group I: Text Message Group Experimental Treatment 1 Intervention

Participants in the intervention arm will have consented for participation in the MedTrack program and will receive the text message intervention and remote support within 1-2 weeks of enrolling.

Group II: Usual Care Active Control 1 Intervention

Participants in the usual care arm will have consented for participation and will be informed they are on a waiting list for approximately 6-12 months. During that time they will receive no additional interventions beyond usual care and not be be invited again to enroll in the MedTrack program.

Who Is Running the Clinical Trial?

Ascension Health

Lead Sponsor

Trials

28

Recruited

543,000+

Brigham and Women's Hospital

Collaborator

Trials

1,694

Recruited

14,790,000+